HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF
US Patent 12,012,463
Filed on 2021-02-05
Filed on 2021-02-05
HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF
European Patent
19759784.2
Filed on 2019-08-06
19759784.2
Filed on 2019-08-06
High Affinity Monoclonal Antibodies Targeting Glypican-2 For Treating Childhood Cancers
China
201980053942.7
Filed on 2019-08-06
201980053942.7
Filed on 2019-08-06
HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF
Canada
3106544
Filed on 2019-08-06
3106544
Filed on 2019-08-06
HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF
Australia
2019317565
Filed on 2019-08-06
2019317565
Filed on 2019-08-06
Furoquinolinedione As Inhibitors Of TDP2
China
202110013140.2
Filed on 2016-01-08
202110013140.2
Filed on 2016-01-08
ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE
Patent Cooperation Treaty
PCT/US2021/014176
Filed on 2021-01-20
PCT/US2021/014176
Filed on 2021-01-20
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Patent Cooperation Treaty
PCT/US2021/019775
Filed on 2021-02-26
PCT/US2021/019775
Filed on 2021-02-26
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION
Patent Cooperation Treaty
PCT/US2021/017852
Filed on 2021-02-12
PCT/US2021/017852
Filed on 2021-02-12
HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION
Patent Cooperation Treaty
PCT/US2021/017794
Filed on 2021-02-12
PCT/US2021/017794
Filed on 2021-02-12